LCD L39189: Mass Spectrometry (MS) Testing in Monoclonal Gammopathy (MG) — Wellpoint Federal
Policy LCD-L39189 · Clinical Laboratory
MS testing coverage for monoclonal gammopathy now active under Wellpoint.
Code intelligence
0012U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0012U.
Normal code risk
Signal breakdown
1 shown · 1 total in platform
Risk: Normal
0
Critical
0%
0
High
0%
1
Routine
100%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Routine
Audit documentation
Building an audit file that includes 0012U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription